Gilead Sciences, Inc (NASDAQ:GILD) currently has a daily average trading volume of 6.29M but it saw 11059795 shares traded in last market. With a market cap of 115.32B USD, the company’s current market price of $92.63 came falling about -1.82 while comparing to the previous closing price of $94.35. In past 52 weeks, the stock remained buoying in the range of price level as high as $98.90 and as low as $62.07. In the recent trading on the day, stock has struck highest price mark of $91.63 while lowest mark touched by it was $94.205.
Taking a look at 20-day trading activity of Gilead Sciences, Inc (GILD) gives us an average price of $90.36, while its current price level is -6.34% below from 52-week high level whereas it is 49.23% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $86.22 while that of 200 days or SMA-200 reads an average of $74.72. A closer look into the stock’s movement over the week reveals that its volatility is standing at 3.19% during that period while stretching the period over a month that decreases to 1.96%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 59.21 which implies that the stock is in neutral territory.
Leerink Partners upgraded its recommendation for the stock as a “Outperform” from “Market Perform” on October 21, 2024 while assigning a price target range of $74-$96. Bernstein issued its recommendations for the stock as it initiated the price target for the stock is $105.
Over the week, GILD’s stock price is moving 1.03% up while it is 7.94% when we observe its performance for the past one month. Year-to-date it is 14.34% up and over the past year, the stock is showing an upside performance of 23.62%.
Currently, Gilead Sciences, Inc’s total number of outstanding shares is 1.25B. Company’s return on investment (ROI) stands at 0.32% and return on equity (ROE) at 0.62%. It has a price to earnings ratio (P/E ratio) of 1044.31 while having a 12.43 of forward P/E ratio. Stock’s beta reads 0.20. Stock has a price to book (P/B) ratio of 6.25 while price to sale or P/S ratio amounts to 4.08. Its return on asset (ROA) is 0.22% on average.
